                               SEQUENCE LISTING

<110> ROOTPATH GENOMICS, INC.
 
<120> COMPOSITIONS AND METHODS FOR T-CELL RECEPTOR IDENTIFICATION

<130> 53563-709.601

<140> PCT/US2021/056208
<141> 2021-10-22

<150> 63/128,274
<151> 2020-12-21

<150> 63/104,624
<151> 2020-10-23

<160> 21    

<170> PatentIn version 3.5

<210> 1
<211> 50
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> SITE
<222> (1)..(50) 
<223> This sequence may encompass 1-10 "Gly Gly Gly Gly Ser" 
      repeating units

<400> 1
Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   10                  15      


Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly 
            20                  25                  30          


Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly 
        35                  40                  45              


Gly Ser 
    50  


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<400> 2
Leu Pro Xaa Thr Gly 
1               5   


<210> 3
<211> 20
<212> PRT
<213> Homo sapiens

<400> 3
Met Ser Arg Ser Val Ala Leu Ala Val Leu Ala Leu Leu Ser Leu Ser 
1               5                   10                  15      


Gly Leu Glu Ala 
            20  


<210> 4
<211> 24
<212> PRT
<213> Homo sapiens

<400> 4
Val Gly Ile Ile Ala Gly Leu Val Leu Leu Gly Ala Val Ile Thr Gly 
1               5                   10                  15      


Ala Val Val Ala Ala Val Met Trp 
            20                  


<210> 5
<211> 5
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Enterokinase cleavage site sequence

<400> 5
Asp Asp Asp Asp Lys 
1               5   


<210> 6
<211> 4
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Factor Xa cleavage site sequence

<400> 6
Ile Glu Gly Arg 
1               


<210> 7
<211> 6
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Thrombin cleavage site sequence

<400> 7
Leu Val Pro Arg Gly Ser 
1               5       


<210> 8
<211> 8
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Renin cleavage site sequence

<400> 8
His Pro Phe His Leu Val Ile His 
1               5               


<210> 9
<211> 4
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: 
      Caspase protease cleavage site sequence

<400> 9
Asp Glu Val Asp 
1               


<210> 10
<211> 20
<212> DNA
<213> Homo sapiens

<400> 10
actcacgctg gatagcctcc                                                   20


<210> 11
<211> 20
<212> DNA
<213> Homo sapiens

<400> 11
gagtagcgcg agcacagcta                                                   20


<210> 12
<211> 20
<212> DNA
<213> Homo sapiens

<400> 12
cagtaagtca acttcaatgt                                                   20


<210> 13
<211> 19
<212> DNA
<213> Homo sapiens

<400> 13
gccgcctccc acttgcgct                                                    19


<210> 14
<211> 20
<212> DNA
<213> Homo sapiens

<400> 14
cacatgcagc ccacgagccg                                                   20


<210> 15
<211> 20
<212> DNA
<213> Homo sapiens

<400> 15
atccctaaat atggtgtccc                                                   20


<210> 16
<211> 20
<212> DNA
<213> Homo sapiens

<400> 16
tccctaaata tggtgtccct                                                   20


<210> 17
<211> 20
<212> DNA
<213> Homo sapiens

<400> 17
gtgatccggg tatgggcagt                                                   20


<210> 18
<211> 20
<212> DNA
<213> Homo sapiens

<400> 18
tgatccgggt atgggcagtg                                                   20


<210> 19
<211> 475
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 19
Met Ser Arg Ser Val Ala Leu Ala Val Leu Ala Leu Leu Ser Leu Ser 
1               5                   10                  15      


Gly Leu Glu Ala Ile Gln Arg Thr Pro Lys Ile Gln Val Tyr Ser Arg 
            20                  25                  30          


His Pro Ala Glu Asn Gly Lys Ser Asn Phe Leu Asn Cys Tyr Val Ser 
        35                  40                  45              


Gly Phe His Pro Ser Asp Ile Glu Val Asp Leu Leu Lys Asn Gly Glu 
    50                  55                  60                  


Arg Ile Glu Lys Val Glu His Ser Asp Leu Ser Phe Ser Lys Asp Trp 
65                  70                  75                  80  


Ser Phe Tyr Leu Leu Tyr Tyr Thr Glu Phe Thr Pro Thr Glu Lys Asp 
                85                  90                  95      


Glu Tyr Ala Cys Arg Val Asn His Val Thr Leu Ser Gln Pro Lys Ile 
            100                 105                 110         


Val Lys Trp Asp Arg Asp Met Gly Gly Gly Gly Ser Gly Gly Gly Gly 
        115                 120                 125             


Ser Gly Gly Gly Gly Ser Gly Ser His Ser Met Arg Tyr Phe Phe Thr 
    130                 135                 140                 


Ser Val Ser Arg Pro Gly Arg Gly Glu Pro Arg Phe Ile Ala Val Gly 
145                 150                 155                 160 


Tyr Val Asp Asp Thr Gln Phe Val Arg Phe Asp Ser Asp Ala Ala Ser 
                165                 170                 175     


Gln Arg Met Glu Pro Arg Ala Pro Trp Ile Glu Gln Glu Gly Pro Glu 
            180                 185                 190         


Tyr Trp Asp Gly Glu Thr Arg Lys Val Lys Ala His Ser Gln Thr His 
        195                 200                 205             


Arg Val Asp Leu Gly Thr Leu Arg Gly Tyr Tyr Asn Gln Ser Glu Ala 
    210                 215                 220                 


Gly Ser His Thr Val Gln Arg Met Tyr Gly Cys Asp Val Gly Ser Asp 
225                 230                 235                 240 


Trp Arg Phe Leu Arg Gly Tyr His Gln Tyr Ala Tyr Asp Gly Lys Asp 
                245                 250                 255     


Tyr Ile Ala Leu Lys Glu Asp Leu Arg Ser Trp Thr Ala Ala Asp Met 
            260                 265                 270         


Ala Ala Gln Thr Thr Lys His Lys Trp Glu Ala Ala His Val Ala Glu 
        275                 280                 285             


Gln Leu Arg Ala Tyr Leu Glu Gly Thr Cys Val Glu Trp Leu Arg Arg 
    290                 295                 300                 


Tyr Leu Glu Asn Gly Lys Glu Thr Leu Gln Arg Thr Asp Ala Pro Lys 
305                 310                 315                 320 


Thr His Met Thr His His Ala Val Ser Asp His Glu Ala Thr Leu Arg 
                325                 330                 335     


Cys Trp Ala Leu Ser Phe Tyr Pro Ala Glu Ile Thr Leu Thr Trp Gln 
            340                 345                 350         


Arg Asp Gly Glu Asp Gln Thr Gln Asp Thr Glu Leu Val Glu Thr Arg 
        355                 360                 365             


Pro Ala Gly Asp Gly Thr Phe Gln Lys Trp Ala Ala Val Val Val Pro 
    370                 375                 380                 


Ser Gly Gln Glu Gln Arg Tyr Thr Cys His Val Gln His Glu Gly Leu 
385                 390                 395                 400 


Pro Lys Pro Leu Thr Leu Arg Trp Glu Pro Ser Ser Gln Pro Thr Ile 
                405                 410                 415     


Pro Ile Val Gly Ile Ile Ala Gly Leu Val Leu Phe Gly Ala Val Ile 
            420                 425                 430         


Thr Gly Ala Val Val Ala Ala Val Met Trp Arg Arg Lys Ser Ser Asp 
        435                 440                 445             


Arg Lys Gly Gly Ser Tyr Ser Gln Ala Ala Ser Ser Asp Ser Ala Gln 
    450                 455                 460                 


Gly Ser Asp Val Ser Leu Thr Ala Cys Lys Val 
465                 470                 475 


<210> 20
<211> 18
<212> DNA
<213> Homo sapiens

<400> 20
tccatctggt catagaag                                                     18


<210> 21
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Asp Ser Ser Leu Gln Ala Arg Leu Phe Pro Gly Leu Thr Ile Lys Ile 
1               5                   10                  15      


Gln Arg Ser Asn Gly Leu Ile His Ser 
            20                  25  


